Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma

Genome Medicine

Volumn 5, Issue 10, 2013, Pages

  Aoki, Yuka ^a   Nojima, Masanori ^a   Suzuki, Hiromu ^a   Yasui, Hiroshi ^a   Maruyama, Reo ^a   Yamamoto, Eiichiro ^a   Ashida, Masami ^a   Itagaki, Mitsuhiro ^b   Asaoku, Hideki ^b   Ikeda, Hiroshi ^a   Hayashi, Toshiaki ^a   Imai, Kohzoh ^c   Mori, Mitsuru ^a   Tokino, Takashi ^a   Ishida, Tadao ^a   Toyota, Minoru ^a   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERROR; PRIORITY JOURNAL;

EID: 84885752915     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm491     Document Type: Article

References (1)

1. Aoki Y, Nojima M, Suzuki H, Yasui H, Maruyama R, Yamamoto E, Ashida M, Itagaki M, Asaoku H, Ikeda H, Hayashi T, Imai K, Mori M, Tokino T, Ishida T, Toyota M, Shinomura Y. Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma. Genome Medicine 2012, 4:101. 10.1186/gm402, 23259664.